SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-006726
Filing Date
2022-10-25
Accepted
2022-10-25 08:30:45
Documents
13
Period of Report
2022-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_102522.htm   iXBRL 8-K 25639
2 EXHIBIT 99.1 exh_991.htm EX-99.1 8710
  Complete submission text file 0001171843-22-006726.txt   210152

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE poai-20221019.xsd EX-101.SCH 3203
4 XBRL LABEL FILE poai-20221019_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE poai-20221019_pre.xml EX-101.PRE 22343
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_102522_htm.xml XML 3592
Mailing Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121
Business Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121 651-389-4800
Predictive Oncology Inc. (Filer) CIK: 0001446159 (see all company filings)

IRS No.: 331007393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36790 | Film No.: 221327252
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies